Camp4 Therapeutics (CAMP) Revenue (2023 - 2026)

Camp4 Therapeutics (CAMP) reported Revenue of $1.3 million for Q1 2026, up 50.82% on a YoY basis from $858000.0 in Q1 2025, and up 271.84% sequentially from $348000.0 in Q4 2025.

Camp4 Therapeutics (CAMP) Revenue (2023 - 2026) Analysis & Trends

Camp4 Therapeutics (CAMP) has 4 years of Revenue data on file, last reported at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 50.82% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 160.53% YoY), and the FY2025 full-year result was $3.5 million, up 436.5% from the prior year.
  • Revenue rose to $1.3 million in Q1 2026, from $348000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.5 million in Q2 2025 to a low of $348000.0 in Q4 2025.
  • A 4-year average of $827714.3 and a median of $795000.0 in 2025 frame the typical range for Revenue.
  • Across the five-year window, Revenue plunged 46.63% in 2025 and soared 50.82% in 2026, its largest moves.
  • Tracing CAMP's Revenue over 4 years: stood at $350000.0 in 2023, then jumped by 86.29% to $652000.0 in 2024, then sank by 46.63% to $348000.0 in 2025, then soared by 271.84% to $1.3 million in 2026.
  • Business Quant data shows CAMP's Revenue at $1.3 million in Q1 2026, $348000.0 in Q4 2025, and $795000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Camp4 Therapeutics 174.35 Mn 174.35 Mn - 1.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.29 Mn
Dec 31, 2025 348,000.00
Sep 30, 2025 795,000.00
Jun 30, 2025 1.50 Mn
Mar 31, 2025 858,000.00
Dec 31, 2024 652,000.00
Sep 30, 2023 350,000.00